LBD represents a spectrum including Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), and dementia with Lewy bodies (DLB) [1–3], which share the same neuropathological marker, namely the intracellular inclusion of alpha-synuclein (Lewy bodies (LB)), as well as clinical features such as visual hallucinations (VH). The gene discussed is SNCA; the disease is Lewy body dementia.